Stock listing

CU2 Stock Price, News, Filings & Events — Cerus Corporation

Selected listing: CU2 · TRADEGATE · EUR · DE

The CU2:TRADEGATE listing represents Cerus Corporation, a company focused on developing and commercializing innovative blood safety products. Cerus is known for its INTERCEPT Blood System, which enhances the safety of blood transfusions by inactivating pathogens. Recent news includes updates on regulatory filings and advancements in their product pipeline, highlighting the company's commitment to improving patient outcomes. Investors can stay informed about upcoming events and market developments that may impact Cerus's operations and growth potential.

CU2:TRADEGATEEURDEUpdated July 24, 2026
Cerus Corporation logo
Ticker
CU2:TRADEGATE
Asset type
Stock
Market cap
$587.1M
Sector
Health Technology
Industry
Medical Specialties
Exchange
TRADEGATE
Currency
EUR

Cerus Corporation CU2:TRADEGATE stock context

The CU2:TRADEGATE listing represents Cerus Corporation, a company focused on developing and commercializing innovative blood safety products. Cerus is known for its INTERCEPT Blood System, which enhances the safety of blood transfusions by inactivating pathogens. Recent news includes updates on regulatory filings and advancements in their product pipeline, highlighting the company's commitment to improving patient outcomes. Investors can stay informed about upcoming events and market developments that may impact Cerus's operations and growth potential.

Research Cerus Corporation

Alternate listings